In a paclitaxel-treated mouse model of breast cancer, tumor cells upregulated the expression of colony-stimulating factor 1 (CSF-1) and resulted in the recruitment of TAMs and resistance to paclitaxel. This evidence concerns the gene CSF1 and neoplasm.